INTERNATIONAL PATENT: DEXCEL PHARMA TECHNOLOGIES LTD FILES APPLICATION FOR "NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF TRANSFERRIN RECEPTOR 2"

GENEVA, April 6 -- DEXCEL PHARMA TECHNOLOGIES LTD (21 Nachum Haftzadi St.9123901 Jerusalem) filed a patent application (PCT/IL2025/050848) for "NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF TRANSFERRIN RECEPTOR 2" on Sep 25, 2025. With publication no. WO/2026/069321, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MARBACH-BAR, Nadav (c/o Dexcel Pharma Technologies Ltd21 Nachum Haftzadi St.9123901 Jerusalem), FEINSTEIN, Elena (c/o Dexcel Pharma Technologies Ltd21 Nachum Haftzadi St.9123901 Jerusalem), MADAR-BALAKIRSKI, Noa (c...